Answer
Evaluation of pharmacokinetic properties is not required for Varivax because it is a vaccine.
Sources for this answer
- VARIVAXMerck Sharp & Dohme (UK) Limited · emc · SmPC §5.2 Pharmacokinetic properties · Version 29Document updated
Sources checked